|
MedChemExpress
cu cpt22 ![]() Cu Cpt22, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cu cpt22/product/MedChemExpress Average 94 stars, based on 1 article reviews
cu cpt22 - by Bioz Stars,
2026-05
94/100 stars
|
Buy from Supplier |
|
TargetMol
cu cpt22 ![]() Cu Cpt22, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cu cpt22/product/TargetMol Average 93 stars, based on 1 article reviews
cu cpt22 - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
s8677 ![]() S8677, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/s8677/product/Selleck Chemicals Average 93 stars, based on 1 article reviews
s8677 - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
|
Tocris
cucpt ![]() Cucpt, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cucpt/product/Tocris Average 94 stars, based on 1 article reviews
cucpt - by Bioz Stars,
2026-05
94/100 stars
|
Buy from Supplier |
|
Tocris
tlr2 inhibitor cu cpt 22 ![]() Tlr2 Inhibitor Cu Cpt 22, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/tlr2 inhibitor cu cpt 22/product/Tocris Average 94 stars, based on 1 article reviews
tlr2 inhibitor cu cpt 22 - by Bioz Stars,
2026-05
94/100 stars
|
Buy from Supplier |
|
Merck KGaA
cu-ctp22 tlr1/tlr2 antagonist ![]() Cu Ctp22 Tlr1/Tlr2 Antagonist, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cu-ctp22 tlr1/tlr2 antagonist/product/Merck KGaA Average 90 stars, based on 1 article reviews
cu-ctp22 tlr1/tlr2 antagonist - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Cayman Chemical
cu-cpt22 ![]() Cu Cpt22, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cu-cpt22/product/Cayman Chemical Average 90 stars, based on 1 article reviews
cu-cpt22 - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Fisher Scientific
cu-cpt22 solution ![]() Cu Cpt22 Solution, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cu-cpt22 solution/product/Fisher Scientific Average 90 stars, based on 1 article reviews
cu-cpt22 solution - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
GlpBio Technology Inc
cu cpt 22 ![]() Cu Cpt 22, supplied by GlpBio Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cu cpt 22/product/GlpBio Technology Inc Average 90 stars, based on 1 article reviews
cu cpt 22 - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
CU CPT 22 is a selective TLR1/2 inhibitor (IC50 = 0.58 μM).
|
Buy from Supplier |
Image Search Results
Journal: Particle and Fibre Toxicology
Article Title: Zinc oxide nanoparticles exacerbate skin epithelial cell damage by upregulating pro-inflammatory cytokines and exosome secretion in M1 macrophages following UVB irradiation-induced skin injury
doi: 10.1186/s12989-024-00571-z
Figure Lengend Snippet: ZnONPs induced cytotoxicity and innate immune responses through Toll-like receptor (TLR) signaling in THP-1-derived macrophages. THP-1 cells were incubated for 24 h in the presence of 10 ng/ml PMA and then exposed to various concentrations of ZnONPs for different times. A Effects of ZnONPs on THP-1-derived macrophage viability after 24 or 48 h. Cell viability was measured by MTT assays. B ZnONP-induced ROS generation in THP-1-derived macrophages. After being exposed to ZnONPs, the cells were incubated with 10 μM DCFH-DA for 30 min to stain H 2 O 2 and analyzed by flow cytometry. Histograms show the percentages of DCFH-DA fluorescence compared with the control. The data are presented as the mean ± SD from three independent experiments. (* p < 0.05, compared with control) C THP-1-derived macrophages were treated with ZnONPs (10 and 15 μg/ml) for 18 h, and the mRNA expression of TLR1, TLR3 and TLR6 was examined by RT‒qPCR and normalized to GAPDH expression. The data were presented as the mean ± SD from three independent experiments. The results showed that ZnONPs significantly triggered TLR1 and TLR3 activation. D THP-1-derived macrophages were treated with ZnONPs (10 μg/ml) for various times, and NFκB (p-p65) protein expression was analyzed by western blotting. E The mRNA levels of the proinflammatory cytokines TNF-α and IL-1β were determined by RT‒qPCR and normalized to GAPDH expression. The data are presented as the mean ± SD from three independent experiments. ZnONPs increased TNF-α and IL-1β mRNA expression at 18 h. (* p < 0.05, ** p < 0.01 compared with control). F THP-1-derived macrophages were treated with ZnONPs (10 μg/ml), and CU-CPT22 or CU-CPT 4a for 16 h, then NFκB (p-p65) protein expression was analyzed by western blotting. CU-CPT22 and CU-CPT 4a are inhibitors specific to TLR1/2 and TLR3, respectively. G Cells were treated with ZnONPs (10 μg/ml), and CU-CPT22 (50 μM) or CU-CPT 4a (30 μM) for 24 h. TNF-α and IL-1β protein levels in the culture medium were measured by ELISA. The data were presented as the mean ± SD from three independent experiments. (* p < 0.05, ** p < 0.01 compared with control, # p < 0.05, ## p < 0.01 compared with ZnONPs alone)
Article Snippet:
Techniques: Derivative Assay, Incubation, Staining, Flow Cytometry, Fluorescence, Control, Expressing, Activation Assay, Western Blot, Enzyme-linked Immunosorbent Assay
Journal: GeroScience
Article Title: Contribution of Porphyromonas gingivalis lipopolysaccharide to experimental periodontitis in relation to aging
doi: 10.1007/s11357-020-00258-1
Figure Lengend Snippet: Age-dependent expressions of Pg-LPS receptors, TLR2, and TLR4, on the surface of CD11b+CSF1r-eGFP+ OCPs. Osteoclast precursors (OCPs) were FACS sorted from the spleen of young (2 months old) and aged (24 months old) CSF1r-eGFP-KI mice and then were stimulated with macrophage colony-stimulating factor (M-CSF) (30 ng/ml) and RANKL (5 ng/ml). After 24 h of stimulation, the expression of TLR2 (a and b) and TLR4 (c and d) was evaluated by multicolor flow cytometry. ***p < 0.001
Article Snippet: FACS-sorted CD11b+CSF1r-eGFP+ OCPs were seeded in 96-well plates at a density of 1 × 10 4 cells/well in α-MEM medium (Life Technologies) containing 10% FBS (Atlanta Biologicals) and 30 ng/ml of M-CSF and 5 ng/ml of RANKL (BioLegend) recombinant proteins in the presence or absence of various concentrations of ultrapure Pg -LPS (1, or 10 ng/ml; InvivoGen),
Techniques: Expressing, Flow Cytometry
Journal: GeroScience
Article Title: Contribution of Porphyromonas gingivalis lipopolysaccharide to experimental periodontitis in relation to aging
doi: 10.1007/s11357-020-00258-1
Figure Lengend Snippet: The effects of Pg-LPS and TLR’s antagonists on RANKL-induced osteoclastogenesis in relation to aging. Microscopic evaluation (a) of the TRAP staining and quantification of the number of TRAP+ multinucleated cells (b) in the RANKL-stimulated young and aged OCPs exposed to Pg-LPS in vitro. Effects of TLR4 (CAS 243984-11-4) and TLR2 antagonists (CU-CPT22) on young (c) and aged (d) RANKL-stimulated OCPs exposed to Pg-LPS. OCPs were FACS sorted from the spleen of young and aged mice and then were stimulated with RANKL in the presence or absence of various concentrations of Pg-LPS as well as TLR2 and TLR4 antagonists. The cells were evaluated at day 6 after stimulation. **p < 0.01, ***p < 0.001
Article Snippet: FACS-sorted CD11b+CSF1r-eGFP+ OCPs were seeded in 96-well plates at a density of 1 × 10 4 cells/well in α-MEM medium (Life Technologies) containing 10% FBS (Atlanta Biologicals) and 30 ng/ml of M-CSF and 5 ng/ml of RANKL (BioLegend) recombinant proteins in the presence or absence of various concentrations of ultrapure Pg -LPS (1, or 10 ng/ml; InvivoGen),
Techniques: Staining, In Vitro